[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@stock_logging Avatar @stock_logging Stock.Logging

Stock.Logging posts on X about business, $2367hk, $mob, $nursv the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence currencies XXXXX% finance XXXXX% cryptocurrencies XXXXX%

Social topic influence business 15.79%, $2367hk #1, $mob #7, $nursv #2, $yb 10.53%, $mluavpa #1, strong 10.53%, $prpo 10.53%, $hytdf #1, exchanges XXXX%

Top accounts mentioned or mentioned by @shravanrayhaan @mufasa_capital @returnsjourney @nestbetter @deepsailcapital @simeonresearch @sycapital @busgus @joinyellowbrick @underlyingvalue @holden_commodor

Top assets mentioned MobileCoin (MOB) YieldBasis (YB)

Top Social Posts

Top posts by engagements in the last XX hours

"$NURS.V $HYTDF Just bought back my previously halved position (I trade the stock on German stock exchanges). ➢This accidental leak in the $VST.CN numbers now reinforces the theory that the terrible communication during the earnings call was due to the inexperience of the persons involved and not an attempt to hide any problems in the core business. But: The leak which was later corrected underscores the impression that communication at Hydreight and Victory Square is anything but professional. ➢In any case with 887000 orders placed YTD they do indeed seem to be on track according to the old"
X Link 2025-12-02T12:32Z 1642 followers, 5492 engagements

"$2367.HK Long Giant Biogene since yesterday. ➢ High quality & deep moat ➢ XX% revenue and profit growth through 2027 ➢ Fwd PE 2026: XX ➢ Insiders buying (already own XX% of shares) ➢ X% div. yield for 2026 ➢ New buyback program for up to XX% of the shares launched Quote regarding the share buyback program that came into effect on December X 2025: "The Board believes that the current share price is lower than its intrinsic value which does not fully reflect the business prospects and asset value of the Company. The Share Repurchase scheme reflects the confidence of the Board and the management"
X Link 2025-12-05T15:39Z 1641 followers, 2660 engagements

"Portfolio Update November 2025 📊 Performance November2025 (measured as TTWROR in EUR): -XXXX% 📊 Performance YTD (measured as TTWROR in EUR): +29.83 % ➡ Holdings (part 1/2): $undisclosed $SLYG.DE $247A.T $HROW $YB $SOFW.TA $ETON $ARYT.TA $NURS.V $ALLIX.PA $MLUAV.PA $MOB $277A.T $0236.KL $DCTH"
X Link 2025-12-07T16:26Z 1643 followers, 1762 engagements

"$2367.HK Anyone looking to diversify their portfolio outside the US might want to take a look at Giant Biogene. ➢ Around XX% projected revenue and profit growth through 2027 ➢ Fwd PE XX for 2025 XX for 2026 and X for 2027 ➢ XX% GM XX% OM XX% ROCE ➢ XXX% dividend yield for 2025 ➢ XX% of balance sheet consists of cash ➢ Debt-free ➢ Strong FCF conversion Business model in short: Giant Biogene is a market leader in cosmetics and medical products based on recombinant i.e. biotechnologically produced collagen. Deep moat thanks to proprietary formulations based on decades of research. They recently"
X Link 2025-11-21T13:29Z 1634 followers, 3282 engagements

"@ReturnsJourney Voxel $VOX.WA Benefit Systems $BFT.WA and Diagnostyka $DIA.WA from are missing. And from / $2367.HK Giant Biogene and $1523.HK Plover Bay should be included"
X Link 2025-11-21T19:14Z 1634 followers, XXX engagements

"➡ Holdings (part 2/2): $9911.HK $4493.T $3496.T $BXN.AX $276A.T $PRPO $DVYSR.ST $HIT 📢 Monthly commentary: The third consecutive month of significant losses. Very frustrating. And I'm lucky that I managed to get an execution on Intellego at SEK XXXXX the day after the Q3 results; otherwise the month would have been considerably worse. In general the ignominious end of this company with the arrest of CEO Claes Lindahl on suspicion of fraud was an extremely valuable learning experience. The seemingly high upside at the time of my investment blinded me to the clearly visible risks. A mistake I"
X Link 2025-12-07T16:27Z 1634 followers, XXX engagements

"$MOB 80m USD mcap pick and shovel play for small military drones & robots. Currently focusing on communication solutions they are now also positioning themselves as a cybersecurity pioneer for drones. Statements from a recent interview with the CEO (linked below): Already one fully scaled production line from one of their Tier X customers upon receiving a DoD contract could mean 20-30m in revenue for $MOB. During Q3/25 call they guided for a 3m USD quarterly revenue run rate and positive fcf til end of 2026 (see picture below). The company is debt-free and has 16m USD in cash. The burn rate"
X Link 2025-11-17T10:54Z 1632 followers, 4262 engagements

"$MOB Mobilicom is the latest addition to my drone basket. Elevator pitch below. Besides that the basket consists of $MLUAV.PA and the undisclosed stock. $MOB is a risky extremely () volatile stock but I see potential for a return of over XX% pa from here over the next 4-5 years. Perhaps I'll do a proper deep dive in the next few weeks"
X Link 2025-11-17T14:43Z 1633 followers, 3490 engagements

"$PRPO Diagnostics company near break-even ➢ Dual engine for profit growth: A - Gross profit growing faster than revenue B - OPEX growing significantly slower than revenue ➢ Valued at 2x EV/Sales TTM 2-5x lower than peers ➢ IMO chance for XX% IRR p.a. over the next X years 📌Elevator Pitch: ➢ Precipio is a company specializing in cancer diagnostics. ➢ Two Segments: X. Pathology Services Division: Diagnostics services for blood cancers. X. Products Division: The company's proprietary test kits which are sold to other labs. ➢ Important: The company's labs are not just revenue generators but also"
X Link 2025-11-26T20:05Z 1631 followers, 1807 engagements

"$YB Strong Q3/25 print from Yuanbao ➢ Revenue +33.59% YoY +8.22% QoQ ➢ EBIT +39.27% YoY +19.08% QoQ ➢ XX% GM XXXX% OM ➢ EPS +20% QoQ Current valuation ➢Fwd. PE 2025: XXXX ➢Fwd. EV/FCF 2025: XXXX () Calculation Achieved from Q1-Q3/2025 were: ➢$2.90 EPS ($3.87 annual.) ➢$169.2 million OCF ($225.6m annual.) ➢OCF more or less = FCF since CAPEX is almost zero ➢$20.65 share price and XXXXXX mcap ➢EV should currently be at $XXX million after Q3/25 Further initial observations: ➢As I suspected after the last quarter (due to the growth in number of new policies) growth is now back above XX% YoY which"
X Link 2025-12-03T10:53Z 1631 followers, 2945 engagements

"I'm not sure if I'd call this stock a Fintwit favorite. Yes a larger account has written about it but otherwise I think it's still relatively unknown. The stock's appeal has been high revenue growth with a scalable business model including margin expansion. I think the story was interesting and coherent but the execution was weak. I'll continue to monitor the stock. Currently I don't trust the management. But if they could get the company profitable again and show revenue growth of over XX% the stock would have very high upside potential. But I'll only believe it when I see it"
X Link 2025-12-10T15:20Z 1643 followers, XX engagements